Investing Profile

Jason Pontin

InvestorVCAngel
General Partner at DCVC
dcvc.com/bio/core/jason-ponti...Palo Alto, California
Photo of Jason Pontin, General Partner at DCVC (Data Collective)
Your Intro Paths to Jason Pontin

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Jason is a member of
Robyn Frankel Network
171 CONNECTIONS
Robyn Frankel Network
171 CONNECTIONS
Robyn Frankel Network
171 CONNECTIONS
Robyn Frankel Network
171 CONNECTIONS
University of Oxford Network
158 CONNECTIONS

Find Jason Pontin on

cb
Current Investing Position
DCVC (Data Collective) General Partner
Investment Range
$5.0M - $25.0M
Sweet Spot
$15.0M
Investments On Record
13
Current Fund Size
$725M

Jason Pontin is on these Sector & Stage Rankings

Jason Pontin's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Kanvas Biosciences
Series AMay 2026$48M
Series AJul 2024$13M
SeedJun 2023$12M
$73M
Proxima
SeedJan 2026$86M
$98M
Co-investors: Omar Hamoui (Mucker Capital)
Relation Therapeutics
Series UnknownDec 2025$26M
SeedMar 2024$35M
SeedJun 2022$25M
$86M
Co-investors: Christine Aylward (Magnetic Ventures), Jonathan Milner
ZwitterCo
Series BJul 2024$58M
Series ASep 2022$33M
$91M
Totus Medicines
Series BDec 2023$66M
Series ADec 2021$40M
$110M
Co-investors: John Hamer (DCVC (Data Collective)), Sarah Cone (Prequel Strategies), Kiersten Stead (DCVC Bio)
Aquafortus
Series AFeb 2023$17M
$25M
Co-investors: Matt Ocko (DCVC (Data Collective))
Aclarity
SeedApr 2022$3M
$19M
Co-investors: Tom Ferguson (Burnt Island Ventures)

Jason Pontin's Experience

General Partner DCVCPresent
Partner DCVCPresent
Board Chair Kanvas BiosciencesPresent
Board Member RecycleyePresent
Board Member Relation TherapeuticsPresent
Board Chair ZwitterCoPresent
Board Member Evonetix LtdPresent
Founding Board Member, Cofounder, and Initial Investor (through Social Impact Capital) Totus MedicinesPresent
Contributing Writer WIREDPresent
Board Chair StrateosPresent
Scientific Advisory Board Member Adlai Nortye Biopharma Co., Ltd.Present
Board Observer and Seed Investor (through Social Impact Capital) Menten AIPresent
Senior Advisor Flagship VenturesPresent
Senior Partner Flagship VenturesPresent
Strategic Advisor ValoPresent
Chairman MIT Enterprise ForumPresent
Editor in Chief Acumen Journal of Life SciencesPresent
Successively: Managing Editor, the Editor, and Editorial Director Red HerringPresent
Board Member ProximaPresent
Board Member Dayhoff LabsPresent
Board Member RelationPresent
Board Member Aquafortus TechnologiesPresent
Board Chair DVLP MedicinesPresent
Board Chair Equilibr.io IncPresent
Scientific Advisory Board Member Newcastle Dive CenterPresent
Senior Advisor Flagship PioneeringPresent
Strategic Advisor Newcastle Dive CenterPresent
Senior Partner Flagship PioneeringPresent
CEO, Editor in Chief, and Publisher Massachusetts Institute of TechnologyPresent
Chairman Newcastle Dive CenterPresent
Editor in Chief Newcastle Dive CenterPresent
Associate Harvard Kennedy SchoolPresent
Senior Editor InfoWorldPresent
Scientific Advisory Board Member Robyn FrankelPresent
Strategic Advisor Robyn FrankelPresent
Chairman Robyn FrankelPresent
Editor in Chief Robyn FrankelPresent

Jason Pontin's Education

University of Oxford BA, MA (Oxon) MA (Oxon)
University of Oxford BA MA (Oxon)